Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Granulomatosis with polyangiitis is the most common vasculitis disease affecting the head and neck.
In patients with recurrent inflammation of the cartilages of the nose, ears, or larynx, you must consider a diagnosis of relapsing polychondritis.
Sjögren’s syndrome (SS) is a systemic autoimmune disorder that is associated with inflammation of the epithelial tissues, including the salivary and lacrimal glands.
The diagnosis of granulomatosis with polyangiitis requires biopsies of involved sites and testing for antineutrophil cytoplasmic antibodies.
Relapsing polychondritis is diagnosed with three of the following signs with positive biopsies from two separate sites and response to steroids: (1) bilateral auricular chondritis, (2) nonerosive seronegative inflammatory polyarthritis, (3) nasal chondritis, (4) ocular inflammation, (5) laryngotracheal chondritis, and (6) audiovestibular damage.
The supraglottis is the most common laryngeal site affected by sarcoidosis. The epiglottis and arytenoids become pale and extremely swollen, giving a “turban-like” appearance.
Eosinophilia with granulomatosis and polyangiitis is characterized by sinusitis, asthma, and tissue and blood eosinophilia.
Inflammatory bowel disease, Crohn’s disease, and ulcerative colitis can cause recurrent aphthous ulcers.
Granulomatosis with polyangiitis (GPA) is a systemic disease characterized by necrotizing granulomas of the upper and lower respiratory tract, vasculitis, and glomerulonephritis. It is the most common granulomatous disease of the head and neck. Rhinologic symptoms include rhinitis, congestion, sinusitis, and inflammation that can be severe and progress to nasal septal perforation or nasal stenosis. GPA affects the larynx and trachea and can cause hoarseness, cough, hemoptysis, wheezing, and stridor and can progress to subglottic stenosis. Oral cavity manifestations include gingival hyperplasia and tooth mobility.
The diagnosis of GPA is based on clinical symptoms, biopsy, and a positive antineutrophil cytoplasmic antibody (C-ANCA) test. C-ANCA is highly specific and sensitive for GPA, but a negative result does not completely rule out GPA. A liberal biopsy of involved nasal mucosa is recommended to look for the characteristic necrotizing granulomas and vasculitis. Isolated oral or laryngeal/tracheal involvement can occur but is less common, and these areas should be biopsied if diagnosis in unclear. Tissue culture should also be done to rule out bacterial or fungal disease.
Since GPA is a systemic disease, it is best treated in a multidisciplinary fashion with specialists from otolaryngology, rheumatology, nephrology, and other fields. Medical treatment includes immunosuppression with cyclophosphamide, methotrexate, or glucocorticoids. In severe cases, the biologic agent rituximab may be indicated. After control of systemic disease, nasal or airway reconstruction may be needed, but care must be taken to control the disease medically to prevent relapse and further damage to airway structures.
Relapsing polychondritis (RP) is a rheumatologic disorder that involves the cartilages of the nose, ears, and airway as well as systemic involvement of the lymph nodes, lungs, and joints. It typically occurs in the fourth decade of life and affects men and women equally. The incidence is three cases per million.
Most cases of RP present with recurrent auricular chondritis and arthropathy. Patients can also have audiovestibular system damage, nasal and laryngotracheal chondritis, cardiovascular vasculitis, and ocular inflammation. Nasal symptoms include crusting, drainage, and epistaxis and are usually brought on by mucosal disruption and cartilage exposure. Chronic inflammation can cause septal perforation and saddle nose deformity. Airway involvement can be severe and lead to stenosis and collapse of the laryngeal cartilages and trachea, causing obstruction, and patients may need tracheostomy.
There is no specific laboratory test for RP, but markers of inflammation are often increased, including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and anti nuclear antibodies (ANAs). There are clinical criteria for the diagnosis or RP and include at least three of the following: (1) bilateral auricular chondritis, (2) non erosive seronegative inflammatory polyarthritis, (3) nasal chondritis, (4) ocular inflammation, (5) laryngotracheal chondritis, and (6) audiovestibular damage. Stricter criteria require at least two separate areas of biopsy-proven chondritis with response to steroid. Biopsy specimens show chondritis, chondrolysis, and perichondritis.
As an autoimmune disease, RP is treated by immunosuppression including corticosteroids and cytotoxic medications. Additional workup may be needed such as imaging, pulmonary function testing, and echocardiography to determine extent of disease. Surgery is directed at the organ system involved and may involve airway and nasal reconstruction.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here